Sivik Global Healthcare LLC Grows Stock Position in Select Medical Holdings Co. (NYSE:SEM)

Sivik Global Healthcare LLC boosted its position in Select Medical Holdings Co. (NYSE:SEM) by 7.1% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 150,000 shares of the health services provider’s stock after acquiring an additional 10,000 shares during the period. Select Medical accounts for approximately 1.5% of Sivik Global Healthcare LLC’s portfolio, making the stock its 28th largest holding. Sivik Global Healthcare LLC owned approximately 0.12% of Select Medical worth $2,828,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Sippican Capital Advisors grew its stake in Select Medical by 7.3% in the 4th quarter. Sippican Capital Advisors now owns 13,354 shares of the health services provider’s stock valued at $252,000 after buying an additional 912 shares in the last quarter. KBC Group NV grew its holdings in Select Medical by 14.0% during the 4th quarter. KBC Group NV now owns 14,883 shares of the health services provider’s stock valued at $281,000 after buying an additional 1,833 shares in the last quarter. Linden Thomas Advisory Services LLC increased its position in shares of Select Medical by 16.1% during the fourth quarter. Linden Thomas Advisory Services LLC now owns 25,576 shares of the health services provider’s stock valued at $482,000 after buying an additional 3,541 shares during the period. CX Institutional lifted its holdings in shares of Select Medical by 8.9% in the fourth quarter. CX Institutional now owns 37,904 shares of the health services provider’s stock worth $714,000 after buying an additional 3,083 shares in the last quarter. Finally, Inspire Investing LLC grew its stake in Select Medical by 78.6% during the fourth quarter. Inspire Investing LLC now owns 21,258 shares of the health services provider’s stock valued at $401,000 after acquiring an additional 9,355 shares in the last quarter. Institutional investors own 89.48% of the company’s stock.

Insider Buying and Selling at Select Medical

In other Select Medical news, VP Robert G. Breighner, Jr. sold 4,989 shares of the stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $19.95, for a total value of $99,530.55. Following the completion of the transaction, the vice president now owns 30,356 shares in the company, valued at approximately $605,602.20. This represents a 14.12 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Marilyn B. Tavenner sold 32,000 shares of the company’s stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total transaction of $674,880.00. Following the completion of the sale, the director now directly owns 22,000 shares in the company, valued at $463,980. This represents a 59.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 19.14% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several brokerages have commented on SEM. UBS Group cut their price target on shares of Select Medical from $40.00 to $21.00 and set a “neutral” rating for the company in a report on Friday, January 3rd. StockNews.com upgraded Select Medical from a “hold” rating to a “buy” rating in a research report on Monday. Royal Bank of Canada raised their price target on Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a report on Monday, November 4th. Finally, Benchmark cut shares of Select Medical from a “buy” rating to a “hold” rating in a research report on Monday, November 25th. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $39.50.

Select Medical Price Performance

Shares of Select Medical stock opened at $19.65 on Thursday. The business’s 50-day moving average price is $20.61 and its 200-day moving average price is $30.16. The firm has a market capitalization of $2.54 billion, a PE ratio of 9.20, a price-to-earnings-growth ratio of 0.65 and a beta of 1.45. Select Medical Holdings Co. has a 12 month low of $18.02 and a 12 month high of $40.98. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37.

Select Medical (NYSE:SEM) last posted its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 EPS for the quarter, topping the consensus estimate of $0.36 by $0.07. The firm had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.74 billion. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The business’s revenue was up 5.7% compared to the same quarter last year. During the same period last year, the firm posted $0.46 earnings per share. Sell-side analysts forecast that Select Medical Holdings Co. will post 1.97 EPS for the current fiscal year.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.